It’s time to bury respiratory syncytial virus in the abyss of immunization fire.
New Drugs
Novel drugs approved by regulators for human use.
A drug is positioned as new if it:
- offers treatment for a disease for which no specific therapy previously existed
- targets a new therapeutic target
- has a new mechanism of action
- is developed in a new formulation, optimized or improved
- is part of a new combination drug
- belongs to a new class of drug compounds.
Posted inNew Drugs, Rare/Orphan Diseases, Regulatory
Wynayre/Wynfidra: Brand New Drug for COPD Maintenance Therapy
Ensifentrine is a medication with a novel mechanism of action for the maintenance treatment of chronic obstructive pulmonary disease.
Posted inClinical Trials, COVID-19, Infections, New Drugs
Nexsheld: Updated Evusheld for Effective Vaccine-Free COVID-19 Protection
Sipavibart injection every six months for reliable prevention of COVID-19.
Posted inCOVID-19, Infections, New Drugs, Regulatory
Pemgarda: For COVID-19 Protection Instead of Vaccines
Pemivibart every three months. For those who cannot receive the COVID-19 vaccine.
Posted inNew Drugs, Oncology, Regulatory
Datroway/Datverzo: Groundbreaking New Way to Treat Lung Cancer
Datopotamab deruxtecan for the treatment of unresectable NSCLC after failure of first-line therapy.
Posted inCardiology, New Drugs, Rare/Orphan Diseases, Regulatory
Winrevair: Game-Changer in Pulmonary Arterial Hypertension Treatment
Sotatercept is the first drug that actually modifies PAH.
Posted inMetabolism, New Drugs, Rare/Orphan Diseases, Regulatory
Lenmeldy/Libmeldy: Most Expensive Drug in the World
Atidarsagen autotemcel is a gene therapy for metachromatic leukodystrophy (MLD).